Sorrento Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Sorrento Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $4.09M, a 19.5% increase year-over-year.
  • Sorrento Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $15.6M, a 25.2% increase year-over-year.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $13.6M, a 21.5% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $11.2M, a 13.6% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $9.88M, a 42.5% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $13.6M +$2.41M +21.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $11.2M +$1.35M +13.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $9.88M +$2.95M +42.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $6.94M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.